US Biguanide Antidiabetics Market Highlights - 2015

  • ID: 3293553
  • Drug Pipelines
  • Region: United States
  • Fore Pharma
1 of 3
The latest research ‘US Biguanide Antidiabetics Market Highlights – 2015’, provides the US Biguanide Antidiabetics market valuation, competitive landscape, and Biguanide Antidiabetics products sales in the US.
The research includes US Biguanide Antidiabetics market size estimates for 2014, Biguanide Antidiabetics products market share, and Biguanide Antidiabetics products sales estimates.
This research helps executives track competitor product sales and market share in the US Biguanide Antidiabetics market. It supports decision making in R&D to long term marketing strategies. The report can be used for evaluating business opportunities, formulating business development strategies, and product positioning in the US Biguanide Antidiabetics market.

Scope of the Research:
- Biguanide Antidiabetics as defined in EphMRA Anatomical Therapeutic Chemical classification code A10J
- Marketed Products: Identify Biguanide Antidiabetics products marketed including brand name, molecule name, and company
- Sales Estimates: Find out estimates for the US Biguanide Antidiabetics market size in 2014, key products and their sales, and how the market and products advanced from 2011. You will benefit from our accurate sales valuation of products and the market
- Competitive Landscape: You will know the market share of leading Biguanide Antidiabetics products in 2014 and how they have changed from 2011
- Pipeline: Find out key Biguanide Antidiabetics products in clinical trial phase 3 and phase 2. Coverage includes molecule, mechanism of action, and the company developing the product

This report will take 1-2 business days to deliver.
Note: Product cover images may vary from those shown
2 of 3
1. Biguanide Antidiabetics Market Definition
2. Biguanide Antidiabetics - Marketed Products
3. US Biguanide Antidiabetics Market Size
4. US Biguanide Antidiabetics Market - Products Sales Analysis
5. US Biguanide Antidiabetics Market - Competitive Landscape
6. Biguanide Antidiabetics - Key Late Stage Pipeline
7. Research Methodology

Table 1: Biguanide Antidiabetics: Marketed Products, 2014
Table 2: US Biguanide Antidiabetics Market Size ($), 2011 - 2014
Table 3: US Biguanide Antidiabetics - Products Sales ($), 2011 - 2014
Table 4: Biguanide Antidiabetics - Key Late Stage Pipeline, 2015

Figure 1: US Biguanide Antidiabetics Market Size ($), 2011 - 2014
Figure 2: US Biguanide Antidiabetics Products Sales ($), 2011 - 2014
Figure 3: US Biguanide Antidiabetics Market - Products Market Share (%), 2014
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll